Abu Dhabi: The Abu Dhabi Ports has announced it will store and distribute more than 70 million COVID-19 vaccines as part of its efforts to supports the global fights against COVID-19.
To that end, the region’s premier facilitator of logistics, transport, and trade said it has dedicated a 19,000 sqm temperature-controlled warehouse – one of the region’s largest pharmaceutical logistics facilities at the Khalifa Industrial Zone Abu Dhabi (KIZAD) for vaccine storage and distribution.
The entity affirmed it is playing a vital role in the global fight against COVID-19, using its enhanced logistics capabilities to store and distribute more than 70m COVID-19 vaccines as part of its commitment to the immunisation drive.
The technologically advanced facility is one of the region’s largest pharmaceutical logistics facilities already housing 1m+ vials of the vaccine. It can store vaccines and other pharmaceutical products at a range of 2 to 8 degrees Celsius and down to 80 degrees.
The facility also follows international best practices consistent with all of Abu Dhabi’s COVID-19 measures.
Abu Dhabi Ports’ advanced infrastructure and multimodal connectivity will enable it to distribute pharmaceuticals quickly across the global supply chain.